SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,188.00
-19.00 (-1.57%)
At close: Oct 2, 2025

SCM Lifescience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
45,03338,70477,366175,143233,826586,015
Upgrade
Market Cap Growth
2.34%-49.97%-55.83%-25.10%-60.10%-
Upgrade
Enterprise Value
36,13540,48065,415170,464217,178551,155
Upgrade
Last Close Price
1141.001891.003780.0010694.0814394.4636522.70
Upgrade
PS Ratio
29.1946.93111.21442.30532.321831.26
Upgrade
PB Ratio
1.852.733.787.155.249.29
Upgrade
P/TBV Ratio
1.882.873.827.245.289.34
Upgrade
EV/Sales Ratio
23.4249.0894.03430.49494.421722.33
Upgrade
Debt / Equity Ratio
0.110.490.190.240.140.11
Upgrade
Asset Turnover
0.060.030.020.010.010.01
Upgrade
Inventory Turnover
2.381.101.531.290.850.55
Upgrade
Quick Ratio
6.340.1810.851.972.2710.85
Upgrade
Current Ratio
6.610.3511.552.202.3311.07
Upgrade
Return on Equity (ROE)
-41.87%-71.44%-106.53%-66.34%-41.82%-23.08%
Upgrade
Return on Assets (ROA)
-21.08%-29.10%-27.81%-18.06%-11.66%-17.14%
Upgrade
Return on Capital (ROIC)
-22.35%-31.11%-29.77%-19.40%-12.61%-20.68%
Upgrade
Earnings Yield
-18.29%-31.98%-30.97%-13.09%-9.63%-1.64%
Upgrade
FCF Yield
-36.76%-36.50%-15.99%-6.67%-6.02%-2.11%
Upgrade
Buyback Yield / Dilution
-10.66%-25.01%-12.85%-21.21%-12.79%-101.51%
Upgrade
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.